Completed PHASE1 INTERVENTIONAL 4-arm NCT05106400

Clinical Adhesion Study Between ZTlido 1.8% and Three Over-the-counter External Analgesic Lidocaine-containing Patches

Open-label, Randomized, Four-treatment, Four-sequence, Four-period, Crossover, Single-application Study Evaluating and Comparing Product Adhesion in Healthy Adult Subjects Using ZTlido 1.8% Versus Salonpas(Lidocaine Patch 4%), Aspercreme(Lidocaine Patch 4%) and IcyHot(Lidocaine 4% + Menthol 1% Patch)

Sponsor: Scilex Pharmaceuticals, Inc.

Conditions Healthy

Interventions Aspercreme (Lidocaine Patch 4%) IcyHot (Lidocaine 4% + Menthol 1% Patch) Salonpas (Lidocaine Patch 4%) ZTlido (Lidocaine Topical System) 1.8%

Updated 3 times since 2021 Last updated: Oct 22, 2021 Started: Jul 1, 2021 Primary completion: Jul 21, 2021 Completion: Jul 21, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Healthy, this trial is completed. The trial is conducted by Scilex Pharmaceuticals, Inc. and has accumulated 3 data snapshots since 2021. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

3 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Dec 2021 — Jul 2024 [monthly]

Completed PHASE1

First recorded

Jul 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Scilex Pharmaceuticals, Inc.

Data source: Scilex Pharmaceuticals, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Dilworth, United States